Blue Jet Healthcare has scheduled its 58th Annual General Meeting (AGM) for Monday, September 21, 2026, at 11:00 am IST. The meeting will be conducted through Video Conferencing or Other Audio Visual Means in compliance with Ministry of Corporate Affairs circulars. The primary agenda includes the adoption of audited standalone financial statements for the financial year ended March 31, 2026, and the approval of key management appointments.

The Board of Directors recommended a final dividend of ₹1.20 per equity share (face value ₹2 each) for FY26 during its meeting on May 25, 2026. The record date for determining dividend entitlement is set for Monday, September 14, 2026. Shareholders holding securities as on this cut-off date are eligible to participate in remote e-voting, which commences on Friday, September 18, 2026, at 9:00 am and concludes on Sunday, September 20, 2026, at 5:00 pm.

Key Agenda Items

The AGM notice outlines several critical resolutions requiring shareholder approval:

• Adoption of Financials: Members will receive, consider, and adopt the Audited Standalone Financial Statements for FY26, along with reports from the Board and Auditors.
• Director Re-appointment: Mr. Naresh Suryakant Shah is proposed for re-appointment as a Whole-Time Director, retiring by rotation.
• Auditor Re-appointment: M/s. KKC & Associates LLP is proposed for re-appointment as Statutory Auditors for a second term of five years, extending until the conclusion of the 63rd AGM in FY31.

Executive Leadership Renewal

A significant portion of the agenda involves the re-appointment of the company’s top leadership for five-year terms effective from April 13, 2027, to April 12, 2032. Both appointments require approval via Special Resolution.

The remuneration packages include basic salaries, house rent allowances, performance-linked incentives, medical benefits, and other statutory contributions. The Board has sought member consent to pay remuneration exceeding limits prescribed under Regulation 17(6)(e) of the SEBI Listing Regulations, if applicable during their tenure.

Voting and Participation Guidelines

Shareholders can cast votes electronically through the MUFG Intime India Private Limited platform. Those holding shares in demat mode may use NSDL or CDSL login methods, while physical shareholders must register via InstaVote. Corporate members are required to submit certified board resolutions authorizing representatives to vote.

Ms. Nupur Gadekar, Partner at M/s. Mehta & Mehta Associates, has been appointed as the scrutinizer for the remote e-voting process, with Ms. Alifiya Sapatwala as the alternate. The Company Secretary, Sweta Poddar, confirmed that the Annual Report and AGM Notice were dispatched electronically on August 18, 2026. Shareholders are advised to update their KYC details with depositories to ensure timely receipt of dividends, which will be paid within thirty days of AGM approval.

Blue Jet Healthcare Limited released its Business Responsibility and Sustainability Report (BRSR) for FY26 on August 18, 2026. The Navi Mumbai-based manufacturer of contrast media, high-intensity sweeteners, and pharmaceutical intermediaries highlighted significant progress in its environmental sustainability metrics during the reporting period.

The company reported a substantial shift in its energy mix, with renewable energy consumption rising by 28% year-on-year. Total renewable energy usage reached 40,836.79 GJ in FY26, up from 26,321.38 GJ in FY25. This increase was driven by the commissioning of a 5.625 MW solar power plant and the installation of a 3.2 MW windmill. Consequently, approximately 57% of the company’s total energy requirements are now met through renewable sources.

Environmental Performance

The expansion of renewable capacity contributed to a measurable decline in carbon emissions. Scope 1 and Scope 2 greenhouse gas emissions decreased to 32,138.47 tCO2e in FY26, down from 34,885.47 tCO2e in FY25. The company also implemented boiler efficiency monitoring and automatic coal combustion control systems, which resulted in a 5–8% reduction in specific emissions including CO2, NOx, and SOx.

Water management remains a critical focus for the chemical manufacturing entity. Blue Jet Healthcare operates a Zero Liquid Discharge (ZLD) system across its facilities. During FY26, the company treated and reused 48,827 KL of water through its Effluent Treatment Plant (ETP) and Reverse Osmosis (RO) systems. Treated water is recycled for utility applications such as cooling towers and boilers, reducing freshwater dependency.

Social and Governance Highlights

On the social front, the company maintained a workforce of 508 employees and 73 workers at the end of FY26. Women represented 37.5% of the Board of Directors and 50% of Key Managerial Personnel. The company reported zero Lost Time Injury Frequency Rate (LTIFR) and zero fatalities for employees and workers during the financial year.

Blue Jet Healthcare obtained reasonable assurance on its BRSR Core KPIs from TÜV India Private Limited. The company also initiated Scope 3 emissions accounting for selected categories in FY26, marking its first year of reporting under this framework. Exports accounted for approximately 90% of total turnover, with operations serving over 50 countries including the USA, Norway, and various European nations.